Diabetes technology

The Virtual Diabetes Control and Complications Trial #4: Relationship of HbA1c and Continuous Glucose Monitoring Metrics with Severe Hypoglycemic Events

Diabetes Technol TherPublished Secondary analysis of the Diabetes Control and Complications Trial (DCCT) randomised trial

Authors' conclusion

Hypoglycemia-focused CGM metrics reproduced by virtual CGM data from the DCCT were strongly associated with SH events, although the positive predictive value was low.

Study context

Population
Individuals with T1D in the Diabetes Control and Complications Trial (DCCT)
Primary endpoint
SH events in relation to HbA1c and CGM metrics
Follow-up
Within the subsequent 90 days
Methodological detailsvirtual continuous glucose monitoring (CGM) profiles generated by multistep machine-learning approach, Poisson regression models
  • Virtual CGM profiles generated by multistep machine-learning approach
  • Poisson regression models

Primary result

As reported in the abstract

SH events · subsequent 90 days

RR for severe hypoglycemia (SH) events per 1% increase in time-below-range (TBR)

1.23

95% CI 1.20–1.27

RR for SH events per 0.5% increase in level 2 hypoglycemia (glucose <54 mg/dL)

1.36

95% CI 1.30–1.43

Further findings

SH events per 0.5 SD change in TBR and level 2 hypoglycemia

Similar pattern when assuming a 0.5 SD change in these metrics

PPV of TBR threshold >6% for SH events

PPV of TBR >6% for SH events
13%

Original publication

The Virtual Diabetes Control and Complications Trial #4: Relationship of HbA1c and Continuous Glucose Monitoring Metrics with Severe Hypoglycemic Events. Diabetes Technol Ther. Published 16 March 2026. doi:10.1177/15209156261432166

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.